These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3167804)

  • 1. Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil.
    Petursson SR
    Cancer; 1988 Nov; 62(9):1899-903. PubMed ID: 3167804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer.
    Orlandi F; Caraci P; Berruti A; Puligheddu B; Pivano G; Dogliotti L; Angeli A
    Ann Oncol; 1994 Oct; 5(8):763-5. PubMed ID: 7826911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
    Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
    Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
    Wu LT; Averbuch SD; Ball DW; de Bustros A; Baylin SB; McGuire WP
    Cancer; 1994 Jan; 73(2):432-6. PubMed ID: 8293411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of malignant APUD cell tumors. Effectiveness of DTIC.
    Kessinger A; Foley JF; Lemon HM
    Cancer; 1983 Mar; 51(5):790-4. PubMed ID: 6295614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
    Deutschbein T; Matuszczyk A; Moeller LC; Unger N; Yuece A; Lahner H; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):540-3. PubMed ID: 21667440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?
    Marchand L; Nozières C; Walter T; Descotes F; Decaussin-Petrucci M; Joly MO; Lapras V; Bournaud C; Borson-Chazot F
    Acta Oncol; 2016 Aug; 55(8):1064-6. PubMed ID: 27173015
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
    Schlumberger M; Abdelmoumene N; Delisle MJ; Couette JE
    Br J Cancer; 1995 Feb; 71(2):363-5. PubMed ID: 7530987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
    Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
    Am J Clin Oncol; 1988 Aug; 11(4):490-5. PubMed ID: 2841843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
    Stein R; Chen S; Reed L; Richel H; Goldenberg DM
    Cancer; 2002 Jan; 94(1):51-61. PubMed ID: 11815960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
    Quayle FJ; Moley JF
    J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study.
    Scherübl H; Raue F; Ziegler R
    J Cancer Res Clin Oncol; 1990; 116(1):21-3. PubMed ID: 2312602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin plus cisplatin in the treatment of apudomas.
    Sridhar KS; Holland JF; Brown JC; Cohen JM; Ohnuma T
    Cancer; 1985 Jun; 55(11):2634-7. PubMed ID: 4039625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report.
    Tanaka K; Sugitani I; Fujimoto Y
    Jpn J Clin Oncol; 2011 Sep; 41(9):1074-8. PubMed ID: 21791572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil.
    Içli F; Arican A; Cay F; Akbulut H; Dinçol D; Karaoğuz H; Demirkazik A
    Oncology; 1999; 56(4):297-300. PubMed ID: 10343193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma.
    Schlumberger M; Ostronoff M; Bellaiche M; Rougier P; Droz JP; Parmentier C
    Cancer; 1988 Apr; 61(8):1492-4. PubMed ID: 3349416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma.
    Schlumberger M; Brugieres L; Gicquel C; Travagli JP; Droz JP; Parmentier C
    Cancer; 1991 Jun; 67(12):2997-3000. PubMed ID: 2044046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
    De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
    Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
    Cano JM; Galán R; López R
    Thyroid; 2017 Nov; 27(11):1450-1455. PubMed ID: 28927353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.